[go: up one dir, main page]

TW200744631A - Lawsonia vaccine and methods of use thereof - Google Patents

Lawsonia vaccine and methods of use thereof

Info

Publication number
TW200744631A
TW200744631A TW095125910A TW95125910A TW200744631A TW 200744631 A TW200744631 A TW 200744631A TW 095125910 A TW095125910 A TW 095125910A TW 95125910 A TW95125910 A TW 95125910A TW 200744631 A TW200744631 A TW 200744631A
Authority
TW
Taiwan
Prior art keywords
methods
vaccination
pregnant sows
lawsonia
vaccine
Prior art date
Application number
TW095125910A
Other languages
English (en)
Inventor
Jeremy Kroll
Michael Roof
Original Assignee
Boehringer Ingelheim Vetmed
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmed filed Critical Boehringer Ingelheim Vetmed
Publication of TW200744631A publication Critical patent/TW200744631A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
TW095125910A 2005-07-15 2006-07-14 Lawsonia vaccine and methods of use thereof TW200744631A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69994605P 2005-07-15 2005-07-15
US11/457,039 US8398994B2 (en) 2005-07-15 2006-07-12 Lawsonia vaccine and methods of use thereof

Publications (1)

Publication Number Publication Date
TW200744631A true TW200744631A (en) 2007-12-16

Family

ID=37311999

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095125910A TW200744631A (en) 2005-07-15 2006-07-14 Lawsonia vaccine and methods of use thereof

Country Status (15)

Country Link
US (2) US8398994B2 (zh)
EP (2) EP2204184B1 (zh)
JP (1) JP2009501730A (zh)
KR (1) KR20080033411A (zh)
AR (1) AR054844A1 (zh)
AU (1) AU2006269965A1 (zh)
BR (1) BRPI0613039A2 (zh)
CA (1) CA2615389A1 (zh)
DK (1) DK2204184T3 (zh)
ES (1) ES2630023T3 (zh)
MX (1) MX2008000349A (zh)
RU (1) RU2420310C2 (zh)
SG (1) SG163598A1 (zh)
TW (1) TW200744631A (zh)
WO (1) WO2007011993A1 (zh)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
US8470336B2 (en) * 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) * 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2164834A2 (en) 2007-07-06 2010-03-24 Boehringer Ingelheim International GmbH Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture
EP2200643B1 (en) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
US20090233830A1 (en) 2008-03-14 2009-09-17 Penny Sue Dirr Automatic detergent dishwashing composition
EP2100947A1 (en) 2008-03-14 2009-09-16 The Procter and Gamble Company Automatic dishwashing detergent composition
TWI551295B (zh) 2008-04-18 2016-10-01 英特威特國際股份有限公司 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）用疫苗
EP2318041B1 (en) * 2008-07-22 2015-02-25 Intervet International BV Lawsonia intracellularis bacterium of a novel serotype, vaccine based on that bacterium, antibodies suitable for diagnosing the novel lawsonia intracellularis serotype and hybridomas for producing the said antibodies
US8142760B2 (en) * 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis
US7931975B2 (en) * 2008-11-07 2011-04-26 Global Oled Technology Llc Electroluminescent device containing a flouranthene compound
KR102012109B1 (ko) * 2012-05-17 2019-08-19 조에티스 엘엘씨 이유 전 돼지 생식기 호흡기 증후군(prrs) 바이러스에 대한 효과적인 백신접종
DK3076997T3 (en) * 2013-12-03 2018-12-10 Intervet Int Bv SVINEVACCINE v PRRS AND LAWSONIA INTRACELLULARIS
JP2018504423A (ja) * 2015-02-04 2018-02-15 インターベット インターナショナル ベー． フェー． 豚における無症候性ローソニア感染症に対する使用のためのワクチン
ES2800033T3 (es) 2015-02-04 2020-12-23 Intervet Int Bv Una vacuna para usar contra la infección asintomática por Lawsonia en un cerdo
RU2018118175A (ru) * 2015-10-22 2019-11-25 Интервет Интернэшнл Б.В. Вакцина для защиты mda-позитивного животного от расстройства, возникающего в результате инфекции, вызванной lawsonia intracellularis
KR20180062468A (ko) * 2016-11-18 2018-06-11 녹십자수의약품(주) 신규한 로소니아 인트라셀룰라리스 균주 및 이의 용도
BR112020017520A2 (pt) * 2018-02-28 2020-12-22 Boehringer Ingelheim Vetmedica Gmbh Método para redução de escatol e/ou indol em animais
WO2021011619A1 (en) * 2019-07-15 2021-01-21 South Dakota Board Of Regents Senecavirus a virus strains and immunogenic compositions therefrom

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
US3479430A (en) * 1967-08-24 1969-11-18 Diamond Lab Inc Indirect passive immunization against transmissible gastroenteritis virus in nursing piglets at birth by active immunization of sows prior to farrowing with transmissible gastroenteritis vaccine and method of producing the same
US3907987A (en) * 1972-05-25 1975-09-23 Canadian Patents Dev Enteric disease vaccine
US4132597A (en) 1976-06-09 1979-01-02 Ab Medipharm Method for cultivation of bacteria
US4237218A (en) 1979-02-09 1980-12-02 Bio-Rad Laboratories, Inc. Micro-carrier cell culture
JPS5991879A (ja) 1982-11-16 1984-05-26 Hideaki Yamada シユ−ドモナス属細菌の培養法
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
DK594084A (da) 1984-12-12 1986-06-13 Novo Industri As Fremgangsmaade til stabilisering af extra-chromosomale elementer i bakterier under dyrkning
JPH0644865B2 (ja) 1985-10-29 1994-06-15 三菱瓦斯化学株式会社 カンピロバクタ−属細菌の培養方法
US5338670A (en) 1986-07-28 1994-08-16 The United States Of America As Represented By The Department Of Health And Human Services Production of bordetella pertussis toxin with a low concentration of iron
IT1227657B (it) 1988-12-01 1991-04-23 Mini Ricerca Scient Tecnolog Antibiotici ab-021 e processo per la loro produzione
JPH0822221B2 (ja) 1988-12-28 1996-03-06 日東化学工業株式会社 シュードモナス属細菌の培養法
JPH02308754A (ja) 1989-05-24 1990-12-21 Yakult Honsha Co Ltd 乳発酵食品の製造法
US5296221A (en) 1990-01-31 1994-03-22 Sani-Ei Sucrochemical Co., Ltd. Lactobacillus johnsonii ferm bp-2680 lactic acid bacteria preparations using the same and a process of manufacturing the preparations
US5192679A (en) 1990-05-03 1993-03-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Growing ehrlichia species in a continuous cell line
CA2094515C (en) 1990-11-01 1998-09-01 Theodore T. Kramer Bacterial attenuation method and vaccine
DE4208785A1 (de) 1992-03-19 1993-09-23 Degussa Verfahren zum auffinden von insertionselementen (is-elemente) oder transposonen
ES2225825T3 (es) * 1992-09-28 2005-03-16 Wyeth Holdings Corporation Procedimiento de mejora de las respuestas inmunitarias mediadas por celulas.
US5610059A (en) 1992-11-09 1997-03-11 University Of Arizona Etiological agent for porcine enteritis
US5885823A (en) 1995-06-05 1999-03-23 Nobl Laboratories, Inc. Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US5714375A (en) 1995-06-05 1998-02-03 Nobl Laboratories, Inc. Ileal symbiont intracellularis propagation in suspended host cells
CN1145697C (zh) 1995-11-30 2004-04-14 维多利亚农业服务控股公司 治疗和诊断组合物
WO2000069906A1 (en) 1999-05-13 2000-11-23 Pfizer Products Inc Lawsonia derived gene and related hemolysin polypeptides, peptides and proteins and their uses
NZ515331A (en) 1999-05-13 2003-07-25 Pfizer Prod Inc Lawsonia derived gene and related FlgE polypeptides, peptides and proteins and their uses
MXPA01011670A (es) 1999-05-13 2003-10-14 Pfizer Prod Inc Gen derivado de lawsonia y polipeptidos, peptidos y proteinas sodc relacionadso y sus usos.
US7052697B1 (en) 1999-05-13 2006-05-30 Agriculture Victoria Services Pty Ltd Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses
US20030157120A1 (en) 1999-05-13 2003-08-21 Michael Panaccio Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
WO2000069905A1 (en) 1999-05-13 2000-11-23 Australian Pork Limited LAWSONIA DERIVED GENE AND RELATED OmpH POLYPEPTIDES, PEPTIDES AND PROTEINS AND THEIR USES
US6414036B1 (en) 1999-09-01 2002-07-02 Van Beek Global/Ninkov Llc Composition for treatment of infections of humans and animals
EP1094070A3 (en) * 1999-10-22 2002-01-09 Pfizer Products Inc. Lawsonia intracellularis proteins, and related methods and materials
US6605696B1 (en) 1999-10-22 2003-08-12 Pfizer, Inc. Lawsonia intracellularis proteins, and related methods and materials
MXPA02011545A (es) 2000-05-24 2003-06-06 Merial Sas Virus del sindrome respiratorio y reproductor porcino (peesv), vacuna recombinante para el virus de la viruela.
MY128159A (en) 2000-06-30 2007-01-31 Wyeth Corp Methods and composition for oral vaccination
HUP0303655A2 (hu) 2000-09-29 2004-03-01 Arizona Board Of Regents On Behalf Of The University Of Arizona Proliferatív ileitis elleni hatékonyabb vakcinák, előállításuk és alkalmazásuk
WO2002028382A1 (en) 2000-10-06 2002-04-11 Van Beek, Ron Compositions for injection or intravenous administration for the treatment of internal infection or inflammation in humans and animals
NZ520600A (en) 2000-11-10 2004-08-27 Agriculture Victoria Serv Pty Novel therapeutic compositions for treating infection by Lawsonia spp
DE60120621T2 (de) 2000-12-20 2006-12-14 Intervet International B. V. Lawsonia intracellularis Impfstoff
WO2003000665A1 (de) 2001-06-22 2003-01-03 Bayer Aktiengesellschaft Antibakterielle uracilderivate.
US20030087421A1 (en) 2001-07-11 2003-05-08 Gebhart Connie J Lawsonia intracellularis
EP1570045A4 (en) 2002-10-04 2007-09-05 Univ Minnesota NUCLEIC ACID AND POLYPEPTIDE SEQUENCES FROM LAWSONIA INTRACELLULARIS AND METHOD OF USE
US7312065B2 (en) 2003-07-25 2007-12-25 Boehringer Ingelheim Vetmedica, Inc. Lawsonia intracellularis of European origin and vaccines, diagnostic agents and methods of use thereof
WO2005026200A2 (en) 2003-09-12 2005-03-24 Akzo Nobel N.V. Lawsonia intracellularis subunit vaccine
MXPA06008217A (es) 2004-01-22 2007-05-23 Intervet Int Bv Vacunas con subunidad de lawsonia intracellularis.
MY146476A (en) 2004-06-24 2012-08-15 Boehringer Ingelheim Vetmed Method of diagnosing lawsonia intracellularis
JP5291281B2 (ja) 2004-06-28 2013-09-18 株式会社渡辺商行 浮上搬送装置及び浮上搬送方法
US7550270B2 (en) 2004-08-13 2009-06-23 Boehringer Ingelheim Vetmedica, Inc. Ileitis diagnostic assay
US20070212373A1 (en) 2004-12-08 2007-09-13 Akzo Nobel N.V. Lawsonia Intracellularis 26 Kd Subunit Vaccine
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
JP2008538502A (ja) 2005-04-18 2008-10-30 ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド サブユニットワクチン中の構成成分として有用なローソニアタンパク並びにその製造方法及び使用方法
AR053372A1 (es) 2005-04-28 2007-05-02 Boehringer Ingelheim Int Proteinas inmunologicas de lawsonia intracellularis
US8398994B2 (en) 2005-07-15 2013-03-19 Boehringer Ingelheim Vetmedica, Inc. Lawsonia vaccine and methods of use thereof
DK1968630T5 (en) 2005-12-29 2018-08-13 Boehringer Ingelheim Vetmedica Inc MULTIVALENT PCV2 IMMUNOGENIC COMPOSITIONS.
US8470336B2 (en) 2006-05-25 2013-06-25 Boehringer Ingelheim Vetmedica, Inc. Vaccination of young animals against Lawsonia intracellularis infections
US20080241190A1 (en) 2006-11-13 2008-10-02 Boehringer Ingelheim Vetmedica, Inc. Vaccination of horses against lawsonia intracellularis
EP2200643B1 (en) 2007-09-17 2013-09-04 Boehringer Ingelheim Vetmedica, Inc. A live lawsonia intracellularis vaccine administered in combination with an antibiotic for use in the treatment of lawsonia intracellularis infections in pigs
US8142760B2 (en) 2008-09-05 2012-03-27 Nathan Len Winkelman Vaccination for Lawsonia intracellularis

Also Published As

Publication number Publication date
CA2615389A1 (en) 2007-01-25
WO2007011993B1 (en) 2007-04-12
RU2420310C2 (ru) 2011-06-10
AU2006269965A1 (en) 2007-01-25
US20070014815A1 (en) 2007-01-18
EP2204184B1 (en) 2017-04-05
US20130164332A1 (en) 2013-06-27
ES2630023T3 (es) 2017-08-17
KR20080033411A (ko) 2008-04-16
EP2204184A1 (en) 2010-07-07
RU2008105348A (ru) 2009-08-20
JP2009501730A (ja) 2009-01-22
US8398994B2 (en) 2013-03-19
SG163598A1 (en) 2010-08-30
MX2008000349A (es) 2008-03-07
DK2204184T3 (en) 2017-07-10
WO2007011993A1 (en) 2007-01-25
EP1917031A1 (en) 2008-05-07
BRPI0613039A2 (pt) 2010-12-14
AR054844A1 (es) 2007-07-18

Similar Documents

Publication Publication Date Title
TW200744631A (en) Lawsonia vaccine and methods of use thereof
MX2009006066A (es) Tratamiento de cerdos con el antigeno pcv.
NO20015073L (no) Vaksiner
MXPA06005639A (es) Adyuvante antimicrobiano.
EP1379125A4 (en) TRANSGENIC ANIMALS THAT EXPRESS SPECIFIC ANTIBODIES FOR INTERESTING GENES AND THEIR USE
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
WO2007140244A3 (en) Vaccination of young animals against lawsonia intracellularis infections
WO2004014367A3 (en) Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease
AU2001284354A1 (en) Immunological adjuvant compounds, compositions, and methods of use thereof
TW200733972A (en) Compositions and methods for the treatment of canine influenza virus disease
HRP20170866T1 (hr) Poboljšano cjepivo za mačji kalicivirus
PH12020552130A1 (en) Vaccination against porcine circoviruses
RU2010143584A (ru) Вакцина для защиты от haemophilus parasuis серотипа 4 у поросят
HUP9700975A2 (hu) Élő, legyengített, Pasteurellaceae családba tartozó, RTX-termelő baktériumok
UA96923C2 (ru) Вакцина на основе lawsonia и способы ее применения
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
AU2003294192A8 (en) Inclusion bodies as antigens for the oral vaccination of animals
ATE373675T1 (de) Impfstoff gegen pferdearteritisvirus
RU2004118892A (ru) Способ специфической профилактики инфекционного эпидидимита баранов
EP1578353A4 (en) METHODS OF USE AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF INFECTION DISEASES
UA102145C2 (ru) Иммуногенная композиция, которая содержит lawsonia intracellularis
AR042035A1 (es) Uso de rmlt como antigeno marcador para vacunas y como un aditivo sinergico con amphigen
RU2004111059A (ru) Способ профилактики парааллергических реакций
TH98870A (th) การให้วัคซีนกับสัตว์อายุน้อยให้ต่อต้านการติดเชื้อLawsonia intracellularis
UA6683U (en) Method of using the biomos preparation in pig feeding